Free Trial

Bruker (BRKR) Competitors

Bruker logo
$29.79 +0.44 (+1.49%)
As of 10:13 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BRKR vs. TECH, A, IQV, MTD, RVTY, TMO, WAT, ILMN, CRL, and BIO

Should you be buying Bruker stock or one of its competitors? The main competitors of Bruker include Bio-Techne (TECH), Agilent Technologies (A), IQVIA (IQV), Mettler-Toledo International (MTD), Revvity (RVTY), Thermo Fisher Scientific (TMO), Waters (WAT), Illumina (ILMN), Charles River Laboratories International (CRL), and Bio-Rad Laboratories (BIO).

Bruker vs. Its Competitors

Bio-Techne (NASDAQ:TECH) and Bruker (NASDAQ:BRKR) are both mid-cap life sciences tools & services companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk, media sentiment and valuation.

Bio-Techne currently has a consensus price target of $70.42, suggesting a potential upside of 33.82%. Bruker has a consensus price target of $51.30, suggesting a potential upside of 72.22%. Given Bruker's higher possible upside, analysts clearly believe Bruker is more favorable than Bio-Techne.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bio-Techne
0 Sell rating(s)
4 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.75
Bruker
0 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.45

Bio-Techne pays an annual dividend of $0.32 per share and has a dividend yield of 0.6%. Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.7%. Bio-Techne pays out 69.6% of its earnings in the form of a dividend. Bruker pays out 38.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Bruker is clearly the better dividend stock, given its higher yield and lower payout ratio.

Bio-Techne has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500. Comparatively, Bruker has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500.

Bruker has higher revenue and earnings than Bio-Techne. Bruker is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bio-Techne$1.22B6.76$73.40M$0.46114.39
Bruker$3.37B1.34$113.10M$0.5257.28

In the previous week, Bruker had 9 more articles in the media than Bio-Techne. MarketBeat recorded 26 mentions for Bruker and 17 mentions for Bio-Techne. Bio-Techne's average media sentiment score of 1.51 beat Bruker's score of 0.67 indicating that Bio-Techne is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bio-Techne
14 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Bruker
14 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
4 Negative mention(s)
1 Very Negative mention(s)
Positive

Bio-Techne has a net margin of 6.02% compared to Bruker's net margin of 2.31%. Bruker's return on equity of 17.89% beat Bio-Techne's return on equity.

Company Net Margins Return on Equity Return on Assets
Bio-Techne6.02% 13.43% 10.32%
Bruker 2.31%17.89%5.38%

99.0% of Bio-Techne shares are owned by institutional investors. Comparatively, 79.5% of Bruker shares are owned by institutional investors. 3.9% of Bio-Techne shares are owned by company insiders. Comparatively, 27.3% of Bruker shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Bio-Techne beats Bruker on 10 of the 19 factors compared between the two stocks.

Get Bruker News Delivered to You Automatically

Sign up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BRKR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BRKR vs. The Competition

MetricBrukerINSTRU IndustryComputer SectorNASDAQ Exchange
Market Cap$4.52B$794.09M$29.97B$9.83B
Dividend Yield0.59%0.59%3.16%4.49%
P/E Ratio57.3123.80419.2126.42
Price / Sales1.341.201,541.37162.19
Price / Cash9.465.6834.3228.92
Price / Book2.482.999.146.53
Net Income$113.10M$17.67M$808.33M$266.04M
7 Day Performance-10.98%-2.84%-1.53%-1.05%
1 Month Performance-14.21%7.82%1.96%4.17%
1 Year Performance-53.74%-24.94%24,060.49%23.95%

Bruker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BRKR
Bruker
4.9978 of 5 stars
$29.79
+1.5%
$51.30
+72.2%
-55.3%$4.52B$3.37B57.3111,396Trending News
Short Interest ↓
Gap Down
TECH
Bio-Techne
4.992 of 5 stars
$56.71
-0.7%
$69.42
+22.4%
-25.6%$8.89B$1.22B123.293,100Positive News
Analyst Forecast
A
Agilent Technologies
4.8266 of 5 stars
$119.15
-2.0%
$139.77
+17.3%
-10.0%$33.85B$6.51B29.4217,900Analyst Revision
IQV
IQVIA
4.8955 of 5 stars
$188.08
-1.6%
$228.62
+21.6%
-26.0%$31.97B$15.41B27.2288,000Positive News
Analyst Forecast
MTD
Mettler-Toledo International
4.2869 of 5 stars
$1,289.88
-2.4%
$1,311.11
+1.6%
-9.4%$26.57B$3.87B32.6617,300Positive News
RVTY
Revvity
3.4574 of 5 stars
$92.12
-2.2%
$120.07
+30.3%
-30.5%$10.69B$2.76B39.0311,000Trending News
Analyst Revision
Gap Down
TMO
Thermo Fisher Scientific
4.9202 of 5 stars
$490.73
-1.9%
$593.00
+20.8%
-20.2%$185.31B$42.88B28.38125,000Positive News
Analyst Forecast
Insider Trade
WAT
Waters
4.7011 of 5 stars
$299.25
-1.0%
$378.73
+26.6%
-14.7%$17.81B$2.96B26.987,600Trending News
ILMN
Illumina
4.9202 of 5 stars
$99.66
-2.1%
$124.58
+25.0%
-26.2%$15.32B$4.37B12.629,030News Coverage
Positive News
Analyst Forecast
CRL
Charles River Laboratories International
3.6513 of 5 stars
$164.03
+1.4%
$175.69
+7.1%
-15.7%$8.07B$4.05B-123.3320,100Short Interest ↑
Analyst Revision
BIO
Bio-Rad Laboratories
4.4283 of 5 stars
$296.61
-2.4%
$333.50
+12.4%
-13.8%$8.03B$2.57B25.297,700News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:BRKR) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners